2024 |
Akero Therapeutics Inc
|
Independent Director |
- |
- |
2023 |
Akero Therapeutics Inc
|
Independent Director |
568.6 K |
313.5 % |
2023 |
Stoke Therapeutics Inc
|
Chairman of the Board |
237.3 K |
-5.9 % |
2022 |
Stoke Therapeutics Inc
|
Chairman of the Board |
252.1 K |
-32.2 % |
2022 |
Akero Therapeutics Inc
|
Independent Director |
137.5 K |
-45.4 % |
2021 |
Stoke Therapeutics Inc
|
Chairman of our Board |
372.0 K |
-20.8 % |
2021 |
Akero Therapeutics Inc
|
Independent Director |
251.6 K |
1.2 % |
2020 |
Stoke Therapeutics Inc
|
Chairman of our Board |
470.0 K |
-10.5 % |
2020 |
Akero Therapeutics Inc
|
Independent Director |
248.5 K |
-34.1 % |
2019 |
Stoke Therapeutics Inc
|
Chairman of our Board |
525.0 K |
- |
2019 |
Akero Therapeutics Inc
|
Independent Director |
377.1 K |
- |
2018 |
Akero Therapeutics Inc
|
Independent Director |
- |
- |
2018 |
Stoke Therapeutics Inc
|
Director |
- |
- |
2017 |
Eledon Pharmaceuticals Inc
|
- |
23.2 K |
-79.9 % |
2017 |
Eledon Pharmaceuticals Inc
|
Chairman of the Board |
- |
- |
2016 |
Eledon Pharmaceuticals Inc
|
Chairman of the Board |
115.3 K |
-35.3 % |
2015 |
Eledon Pharmaceuticals Inc
|
Chairman of the Board |
178.3 K |
517.3 % |
2014 |
Eledon Pharmaceuticals Inc
|
Chairman of the Board |
28.9 K |
- |
2013 |
Eledon Pharmaceuticals Inc
|
Chairman of the Board |
- |
- |